AstraZeneca’s AZD1222 vaccine demonstrates promising efficacy

This article was originally published here

The high-level results from an interim analysis, including 131 Covid-19, have shown no hospitalisations or severe cases of the disease in participants receiving the vaccine. AZD1222, co-invented by

The post AstraZeneca’s AZD1222 vaccine demonstrates promising efficacy appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply